drugset / Trial / NCT00239330
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of the study is to compare the efficacy of rosuvastatin 10 mg with atorvastatin 10 mg by assessment of the percentage of subjects who reach EAS LDL-C target goals after 12 weeks of therapy.
Timeline
- Start
- 2003-06
- Primary completion
- 2005-02
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 10 mg | — |